Prognostic impact of DDR mutations (mt) in IDH mutant high-grade gliomas (HGG). A phase 1, first-in-human study of regorafenib plus temozolomide with or without radiotherapy in patients with newly ...
Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: The SUCCESS trial. Simple oral therapy with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results